Skip to content

Cal-Maine Foods CALM Offering Costs Incurred

Offering Costs Incurred at other companies

Golub Capital logo
Golub CapitalGBDC
$288.04M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$0-100%
TRV
Trevi Therapeutics, Inc.TRVI
$58.25K
TRV
Trevi Therapeutics, Inc.TRVI
$58.25K
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%
Seadrill logo
SeadrillSDRL
$0

Other financials

Income statement

See full
Revenue$667.0M-53.0%
Gross profit$119.3M-83.3%
Operating income$35.9M-94.3%
Net income$50.5M-90.1%
EPS (diluted)$1.06-89.8%

Balance sheet

See full
Cash & equivalents$394.0M-20.8%
Total debt$1.7M-35.7%
Total equity$2.7B+13.4%
Total assets$3.1B+1.9%

Cash flow

See full
Operating cash flow$103.6M-81.9%
CapEx$31.6M-36.6%
Free cash flow$72.0M-86.2%

Valuation

See full
Market cap$3.77B-6.3%

Profitability

See full
Gross margin33.8%-5.9pp
Operating margin24.4%-8.3pp
Net margin20.1%-6.0pp
FCF margin20.8%-1.8pp

Returns & leverage

See full
Return on equity27.4%-20.9pp
Debt / equity0.0×
Current ratio8.2×+4.4×

Where this comes from

Reported directly by Cal-Maine Foods in its filing.

Tagged under the XBRL concept calm:OfferingCostsIncurred.

The official record: Cal-Maine Foods’s 10-K, filed July 22, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cal-Maine Foods's offering costs incurred.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cal-Maine Foods's offering costs incurred?
Cal-Maine Foods (CALM) reported offering costs incurred of $1.7M in Q1 2025.
What does offering costs incurred mean?
The cumulative direct costs associated with the issuance of new equity or debt securities, such as underwriting fees, legal expenses, and registration costs. These costs are typically deferred and amortized or offset against the proceeds of the offering. Tracking these costs provides insight into the efficiency of the company's capital-raising activities.